Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice. - Wikidata - awgldk - TriplyDB

Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice.

Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice.

http://www.wikidata.org/entity/Q39961417

about

Fibrates, glitazones, and peroxisome proliferator-activated receptors Beneficial effects of omega-3 fatty acids on the consequences of a fructose diet are not mediated by PPAR delta or PGC1 alpha PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD.MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells.PPARδ activation attenuates hepatic steatosis in Ldlr-/- mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity Clustering nuclear receptors in liver regeneration identifies candidate modulators of hepatocyte proliferation and hepatocarcinoma Genome-wide association study of swine farrowing traits. Part II: Bayesian analysis of marker data.PKR-like endoplasmic reticulum kinase is necessary for lipogenic activation during HCMV infection.Involvement of oxygen-regulated protein 150 in AMP-activated protein kinase-mediated alleviation of lipid-induced endoplasmic reticulum stress.Anthocyanin inhibits high glucose-induced hepatic mtGPAT1 activation and prevents fatty acid synthesis through PKCζ.Biochemical and physiological function of stearoyl-CoA desaturase.PPARδ agonists have opposing effects on insulin resistance in high fat-fed rats and mice due to different metabolic responses in muscle.E2F8 promotes hepatic steatosis through FABP3 expression in diet-induced obesity in zebrafish.Conditional Expression of Human PPARδ and a Dominant Negative Variant of hPPARδ In Vivo Activation of PPAR-δ induces microRNA-100 and decreases the uptake of very low-density lipoprotein in endothelial cells.PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.Treatment with PPARα Agonist Clofibrate Inhibits the Transcription and Activation of SREBPs and Reduces Triglyceride and Cholesterol Levels in Liver of Broiler Chickens.PPARδ activation protects endothelial function in diabetic mice.PPAR-delta in Vascular Pathophysiology.PPARβ/δ modulates ethanol-induced hepatic effects by decreasing pyridoxal kinase activity.Regulation of bile acid and cholesterol metabolism by PPARs Sorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in cell proliferation and cancer.Regulation of peroxisome proliferator-activated receptor-beta/delta by the APC/beta-CATENIN pathway and nonsteroidal antiinflammatory drugs.Review article: novel methods for the treatment of non-alcoholic steatohepatitis - targeting the gut immune system to decrease the systemic inflammatory response without immune suppression.Oleanolic acid ameliorates high glucose-induced endothelial dysfunction via PPARδ activation.PPARs and Mitochondrial Metabolism: From NAFLD to HCC.Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice Targeting PPARβ/δ for the treatment of type 2 diabetes mellitus.Pharmacological agents for NASH.Nutraceuticals and functional foods in the management of hyperlipidemia.Evolving therapies for non-alcoholic steatohepatitis.Exercise and Omega-3 Polyunsaturated Fatty Acid Supplementation for the Treatment of Hepatic Steatosis in Hyperphagic OLETF Rats Nonalcoholic fatty liver disease - current status and future directions.Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans.Novel Pharmacotherapy Options for NASH.PPARα Is Required for PPARδ Action in Regulation of Body Weight and Hepatic Steatosis in Mice.Orphan nuclear receptor NR4A2 inhibits hepatic stellate cell proliferation through MAPK pathway in liver fibrosis Carvedilol attenuates the progression of alcohol fatty liver disease in rats.Dietary capsaicin prevents nonalcoholic fatty liver disease through transient receptor potential vanilloid 1-mediated peroxisome proliferator-activated receptor δ activation.

P2860

Q28279732-E24862EE-949F-4984-A84A-3EC856060B14 Q28580880-399E9372-69D0-4A7A-B511-70164657E89A Q30241952-46437648-7DEB-4D44-8883-4421991BBD42 Q33734042-D0085F68-80A5-407D-8AE5-DE8FDCD0150E Q33825128-83B4DD0E-9931-4C52-ACB8-BD9F8556885B Q34035095-B8F6EFA8-E5B2-4815-AD9D-CFD7F776524B Q34268862-7BA14C00-D031-48D2-8712-0419547C807B Q34671888-F3212EAE-2B67-4F24-897E-28F481957265 Q34719522-98F4CDC6-622B-4DCB-844E-7C52CBF22001 Q34776293-515999E7-1E92-4767-8526-1B4FB603C562 Q34898764-92FCFD70-D5D5-4E08-9F2E-D6E48764B9EF Q35005682-99F9A4AA-9BFA-4D47-A40C-8DD5166D306C Q35686638-1C4AF390-DB63-4C8B-8C13-C831BB5741BB Q35884894-9E7D9509-B066-4A44-A5D0-8FAC4D54257D Q35911725-278517ED-1CA5-4A7A-B4F3-A2D369452B16 Q36253614-13F87CAD-0831-4CFD-959E-41EB270804D9 Q36360487-7F4C74DA-E117-4D1C-BB23-8C570BC2606E Q36410664-390ACBF7-4046-44C2-B934-F0F12F4BF892 Q37037802-9CF27D79-EB7D-4872-B375-6B0541F542BB Q37262875-50A7810B-39B6-4FE1-B57E-DE008B7C0A29 Q37266779-9D5B8A16-D41D-4BE3-8A69-25F1938CA816 Q37388607-FFAA2BA0-D87D-4B0F-A89D-773A0B32BD7F Q37464651-D07F07CE-A7C4-4F20-BF53-FFDF88C79F76 Q37563673-5201245A-65E4-4794-8E68-9E5B5657212B Q37571295-C49B3298-2D17-483C-A2AD-79C72B047CC4 Q37575571-3C152F52-AA9F-4A39-8AD6-DEC924F89B22 Q37613094-6843ADE3-7E0A-4EBD-B52F-F28FF330C51C Q37978926-6C448A59-58A1-4164-B54B-58C619CEFB0B Q38152646-23414A7B-998E-454C-A287-4383F1A4A4DB Q38185452-C0997AD1-0D0E-451F-AD8A-E677320F73AA Q38207111-4BFBA6CB-3A0B-46A4-A52F-36D090BE1D5A Q38384889-A760ED21-1D08-44AA-B98E-98E819509224 Q38592767-96B9C8DB-A458-4242-A1A8-0B73878ADE06 Q38698442-3E9B8755-86C8-40EF-AB2C-CAD7DF631056 Q38752520-5363FD43-9756-4800-B231-48AE8240C840 Q38784790-432F2CC4-C560-438F-8AD2-0247F53EDE4D Q41862761-C0DC3A99-6116-45B8-AC37-FE405BB59870 Q41983403-0C482ECE-5D09-4C7D-8BB6-216A9D913326 Q42720548-417D4AC9-219B-42F3-BFFE-8AA8EFE2B5E8 Q44206097-5BDFCEA8-8410-4530-927F-7D70ADEBFD0A

P2860

Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice.

http://www.wikidata.org/entity/Q39961417

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Peroxisome proliferator-activa ...... enesis in obese diabetic mice.

@en

Peroxisome proliferator-activa ...... enesis in obese diabetic mice.

@nl

type

label

Peroxisome proliferator-activa ...... enesis in obese diabetic mice.

@en

Peroxisome proliferator-activa ...... enesis in obese diabetic mice.

@nl

prefLabel

Peroxisome proliferator-activa ...... enesis in obese diabetic mice.

@en

Peroxisome proliferator-activa ...... enesis in obese diabetic mice.

@nl

P1433

Q39961417-3A7688E3-5642-4B97-B91B-C6676EC0BA80

P1476

Q39961417-6EF8B454-6A70-4CFC-95C3-2619C2D817C3

P2093

Q39961417-07F30222-1C8A-4D7F-A6BF-3B856590CFB5

Q39961417-201B8515-5F9F-4461-85C5-E1B408F940A3

Q39961417-24DBD7CE-1DF7-4210-9CF3-852260B5F239

Q39961417-2AD32F5A-688F-4476-94B7-BAD3589CA337

Q39961417-3CC2111A-03DA-4210-8324-1B62024B6A31

Q39961417-F1D22FEB-C0A8-44B1-8B47-7184F24F8945

Q39961417-FA1A5D40-DBF9-4BC4-8FCD-0DE6A97334F5

Q39961417-FECEF9BA-EC17-445C-A063-3A365A6EAE5C

P2860

Q39961417-36F75146-3332-42B3-B028-BC19C33B689E

Q39961417-9AF5AB68-DA0A-42BD-8123-55C9862D1C1A

P304

Q39961417-9173B0CF-48E6-4FDF-BE13-F722F664B52A

P31

Q39961417-46F61B88-88F2-4E0D-9679-E4852BC17DF8

P356

Q39961417-111CB47E-1DEF-4D62-897C-374C7D685002

P407

Q39961417-04B11949-C344-4377-ABB8-E03A75481DDD

P433

Q39961417-4F31F061-0D4D-404B-BBEF-0219869F15FC

P478

Q39961417-5D2CCDA9-D160-4C2B-81F8-575C5A793C75

P577

Q39961417-C482BF55-71F4-4CAB-B3E0-706252ADB444

P5875

Q39961417-9D5BFFA3-29B0-4A25-A6A1-1DE218F1641B

P698

Q39961417-31F9702D-4C00-4125-BB9B-1A094B22EE84

P921

Q39961417-045101E9-5B07-44FA-8DDA-7D169FFEE760

P356

P1433

P1476

Peroxisome proliferator-activa ...... enesis in obese diabetic mice.

@en

P2093

Jianwei Tian

http://www.w3.org/2001/XMLSchema#string

Nanping Wang

http://www.w3.org/2001/XMLSchema#string

Xian Wang

http://www.w3.org/2001/XMLSchema#string

Xiaomei Qin

http://www.w3.org/2001/XMLSchema#string

Xuefen Xie

http://www.w3.org/2001/XMLSchema#string

Yanbo Fan

http://www.w3.org/2001/XMLSchema#string

Yi Zhu

http://www.w3.org/2001/XMLSchema#string

Youfei Guan

http://www.w3.org/2001/XMLSchema#string

P2860

Adenovirus-mediated overexpression of c-Jun and c-Fos induces intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human endothelial cells

c-Jun triggers apoptosis in human vascular endothelial cells.

P304

432-441

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.22334

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5225336

http://www.w3.org/2001/XMLSchema#string

P698

18627005

http://www.w3.org/2001/XMLSchema#string

P921